Beijing Tiantan Biological Products Corp Ltd (600161)

Currency in CNY
15.49
+0.51(+3.41%)
Delayed Data·
Earnings results expected in 14 days
600161 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.8715.67
52 wk Range
14.5022.08
Key Statistics
Bid/Ask
15.48 / 15.49
Prev. Close
14.98
Open
14.97
Day's Range
14.87-15.67
52 wk Range
14.5-22.08
Volume
15.9M
Average Vol. (3m)
10.1M
1-Year Change
-26.3433%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600161 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.20
Upside
+30.41%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.

Employees
5298
Market
China

Compare 600161 to Peers and Sector

Metrics to compare
600161
Peers
Sector
Relationship
P/E Ratio
27.2x26.5x−0.5x
PEG Ratio
−0.920.150.00
Price / Book
2.5x2.1x2.6x
Price / LTM Sales
4.8x5.9x3.2x
Upside (Analyst Target)
34.8%22.4%45.7%
Fair Value Upside
Unlock17.2%4.8%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.20
(+30.41% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold22.60+45.90%32.00DowngradeAug 14, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.55%
Dividend Yield
1.69%
Industry Median 1.53%
Annualized Payout
0.25
Paid unevenly
5-Years Growth
+23.58%
Growth Streak

Earnings

Latest Release
Mar 27, 2026
EPS / Forecast
0.14 / 0.24
Revenue / Forecast
1.7B / 2.16B
EPS Revisions
Last 90 days

600161 Income Statement

People Also Watch

15.47
002465
-0.19%
21.97
601066
+0.60%
59.18
600660
+0.25%

FAQ

What Is the Beijing Tiantan Bio (600161) Stock Price Today?

The Beijing Tiantan Bio stock price today is 15.49 CNY.

What Stock Exchange Does Beijing Tiantan Bio Trade On?

Beijing Tiantan Bio is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Beijing Tiantan Bio?

The stock symbol for Beijing Tiantan Bio is "600161."

Does Beijing Tiantan Bio Pay Dividends? What’s The Current Dividend Yield?

The Beijing Tiantan Bio dividend yield is 1.69%.

What Is the Beijing Tiantan Bio Market Cap?

As of today, Beijing Tiantan Bio market cap is 30.63B CNY.

What Is Beijing Tiantan Bio's Earnings Per Share (TTM)?

The Beijing Tiantan Bio EPS (TTM) is 0.55.

When Is the Next Beijing Tiantan Bio Earnings Date?

Beijing Tiantan Bio will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is 600161 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Beijing Tiantan Bio Stock Split?

Beijing Tiantan Bio has split 9 times.

How Many Employees Does Beijing Tiantan Bio Have?

Beijing Tiantan Bio has 5298 employees.

What is the current trading status of Beijing Tiantan Bio (600161)?

As of Apr 16, 2026, Beijing Tiantan Bio (600161) is trading at a price of 15.49 CNY, with a previous close of 14.98 CNY. The stock has fluctuated within a day range of 14.87 CNY to 15.67 CNY, while its 52-week range spans from 14.50 CNY to 22.08 CNY.

What Is Beijing Tiantan Bio (600161) Price Target According to Analysts?

The average 12-month price target for Beijing Tiantan Bio is 20.20 CNY, with a high estimate of 24 CNY and a low estimate of 16.4 CNY. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +30.41% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.